Blog Archives

SABio Now Offers Synthetic Peptides

9/15/2012

SABio now offers peptides in additions to other quality biologics such as RNA oligos, siRNA and antibodies.

We are pleased to announce that SABio has added synthetic peptides to the catalogue of its quality biologics.

Please visit our peptide page for more information or request your custom quotation by filling this easy online form.

We offer:

Standard 5-30-mer peptides
Longer (>30aa) peptides
Amounts from milligrams to grams
Purity level of your choice – from crude to >98%
Variety of modifications (N-, C-terminal, intra-sequence, special amino acids etc.)
Mass spectral analysis and HPLC tracing reports included with each order
Competitive pricing & volume discounts for large orders

0 Comments

SABio Appoints Kristina Rutkute Managing Director

9/1/2012

0 Comments

Dr. Kristina Rutkute

Singapore, 1 September 2012. Singapore Advanced Biologics (“SABio”) announced today the appointment of Dr Kristina Rutkute to the position of Managing Director. Dr. Rutkute has more than 10 years of experience in the biotech industry and research, covering a broad spectrum from assay development to quality assurance and business partnerships.

“We are delighted to have been able to attract Kristina to join the SABio team initially as the business development manager and congratulate her on the current appointment as the Managing Director of SABio ” said A/Prof Subhash Vasudevan, a founder and member of the Board of Directors of SABio.

“Kristina’s demonstrated success in engaging critical stakeholders of the companies where she has worked and her focused leadership style will be critical as we work to grow SABio and bring its products to the market” said Mr Damien Lim, General Partner of BioVeda Capital and a member of the SABio board.

Said Dr. Rutkute, “I look forward to lead and continue to grow SABio into a profitable company that can serve the biologics needs of the research communities in the universities, research institutes, academic medicine centers of public hospitals and biotech/pharmaceutical companies in Singapore and the region.”

Dr. Rutkute was previously with Acumen Research Laboratories, and the Institute of Molecular & Cell Biology at A*STAR. She received her B.Sc in Biochemistry and a M.Sc in Medical Biology from Vilnius University, Lithuania, and a Ph.D. in Physiology from the University of Kentucky, College of Medicine, USA.

0 Comments

SABio Now Offers Synthetic Peptides

SABio Appoints Kristina Rutkute Managing Director

Archives

Categories